Horizon Therapeutics Public Ltd Co

MACKENZIE FINANCIAL CORP

Report date

9/30/2023

Quarter

2023 Q3

Filed

10/25/2023

Shares

10,901

Value ($000)

1,267

Weight

0.0%

2020 Q3 - 2023 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	10/25/2023	1,267	0.0%	10,901	9/30/2023
2023 Q2	8/3/2023	1,142	0.0%	11,082	6/30/2023
2023 Q1	4/24/2023	5,491	0.0%	50,313	3/31/2023
2022 Q3	10/7/2022	4,921	0.0%	79,514	9/30/2022
2022 Q2	8/10/2022	6,556	0.0%	82,202	6/30/2022
2022 Q1	5/13/2022	6,804	0.0%	64,673	3/31/2022
2021 Q4	2/14/2022	3,368	0.0%	31,257	12/31/2021
2021 Q3	11/8/2021	5,723	0.0%	52,243	9/30/2021
2021 Q2	8/11/2021	1,053	0.0%	11,247	6/30/2021
2021 Q1	5/14/2021	1,016	0.0%	11,038	3/31/2021
2020 Q4	2/10/2021	2,018	0.0%	27,592	12/31/2020
2020 Q3	11/13/2020	1,395	0.0%	17,957	9/30/2020